Related Experiment Video
Updated: Jul 14, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Risk factors, pulmonary function, and mortality
Abstract:
In a genetic-epidemiologic study of obstructive airway disease (OAD), cross sectional and longitudinal data (4.7 year follow-up) were collected to investigate relationships among risk factors, pulmonary function, and mortality. In the cross sectional evaluation of 2539 non-patient adults, 11 potential risk factors were found to be significantly associated with airways obstruction. Most important among these were age and smoking. Others included: demographic variables (gender, SES, education); the intake of coffee and diet soda; genetic markers (protease inhibitor "Pi" type, ABO type, ABH secretor status); and familial pulmonary disease. Examination of combinations of risk factors in cross sectional data indicated that some of these factors were important risk factors in cigarette smokers but less evident in never smokers. For example, ABO type, familial component, coffee drinking and diet soda intake were related to marked differences in lung function in cigarette smokers, but had little impact in never smokers. Thus, interactions of factors must be considered when assessing risk of pulmonary dysfunction. In the longitudinal evaluation, 11 factors found to be significant on cross sectional study plus 4 tests of lung function (closing capacity, diffusing capacity, slope of Phase III, and flow volume curves) were examined for correlations with loss of forced expiratory volume. Consistently greater declines of lung function were noted in males, older subjects, smokers, whites, and individuals carrying the type A blood group allele. Increased initial visit closing capacity was also associated with increased deterioration. Together, however, these factors accounted for only a modest amount of observed variation in decline in lung function (17% in females and 12% in males). Initial visit characteristics were not only associated with deterioration of lung function in survivors, as described above, but with survivorship per se. Age, sex, race and cigarette smoking were associated with differences in mortality. In addition to these, pulmonary dysfunction itself at initial visit was an independent risk factor for increased mortality. For example, the mortality of unobstructed males in the 5th decade of life was 16 per thousand compared to 25 per thousand in obstructed males. For females, the mortality in the 5th decade of life was 7 per thousand if unobstructed and 12 per thousand if obstructed. We conclude: 1) In cross sectional evaluation, multiple factors are associated with airways obstruction. Of these, smoking appears to interact strongly with other factors.(ABSTRACT TRUNCATED AT 400 WORDS)
Related Concept Videos
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease I: Introduction

